Compare ImmunityBio Inc. Common Stock (IBRX) vs MKS Instruments (MKSI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ImmunityBio Inc. Common Stock vs MKS Instruments — how do they compare? ImmunityBio Inc. Common Stock trades at $10.57 (market cap $10.51B), while MKS Instruments trades at $265.61 (market cap $17.61B). The key difference: MKS Instruments is the larger of the two by market cap, and MKS Instruments pays a 0.38% dividend while ImmunityBio Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 1 Days and MKS Instruments for 7 Days on average.
| IBRX | MKSI | |
|---|---|---|
Market Cap | $10.51B | $17.61B |
Volume | 10,445,785 | 1,275,355 |
Sector | Health | Technology |
52-Week High | $11.55 | $444.80 |
52-Week Low | $1.98 | $121.26 |
Typical Hold Time | 1 Days | 7 Days |
Enterprise Value | $10.97B | $21.18B |
Dividend Yield | — | 0.38% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About ImmunityBio Inc. Common Stock
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →About MKS Instruments
MKS develops instruments, systems, and process control solutions for advanced manufacturing. Its technologies serve semiconductor manufacturing, electronics and packaging, photonics, and specialty industrial applications.
Read more on MKSI →
